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An overview of surveillance methods and systems for Shigella infections is available online at  
http://www.cdc.gov/ncezid/dfwed/PDFs/Shigella-Overview-508.pdf (1).
Human Surveillance Data: Laboratory-based Enteric Disease Surveillance (LEDS)
The Laboratory-based Enteric Disease Surveillance (LEDS) system collects reports of isolates from laboratory-
confirmed human Shigella infections from state public health laboratories. Reporting to LEDS is voluntary, and 
the number of states submitting isolates varies somewhat from year to year although almost all states report 
every year. Occasionally, more than one isolate is reported from a single episode of infection in a person; this 
report includes only one isolate of a given Shigella species per person within a 30-day period. 
In this report, we summarize the number of infections reported and also report incidence rates (cases per 
100,000 population), which are calculated as the number of Shigella infections in humans reported for a given 
year, divided by the state population for that year. Data were received from 49 of 51 reporting jurisdictions  
(50 states plus the District of Columbia) in 2010.
Data in this report current as of 1/14/2013.
Photograph depicting the colonial morphology displayed by Shigella boydii bacteria cultivated on a 
Hektoen enteric (HE) agar surface.
Page 2 of 10June 2013
Table 1. Laboratory-confirmed Shigella infections reported to CDC, by species, United States, 2010
Rank Serotype Number Reported Percent
1 S. sonnei 7122 79.5
2 S. flexneri 1026 11.5
3 S. boydii 73 0.9
4 S. dysenteriae 34 0.4
Sub Total 8256 92.1
Unknown 707 7.9
Sub Total 707 7.9
Total 8962 100
State public health laboratories reported 8,962 laboratory-confirmed Shigella infections to CDC through LEDS
 • Of the 8,962 isolates, 8,256 (92%) were identified to species level.  
 • Distribution by species was similar to previous years, with Shigella sonnei accounting for the largest percentage 
of infections (79.5%), followed by Shigella flexneri (11.5%), Shigella boydii (0.9%), and Shigella dysenteriae (0.4%). 
Table 2. Median age (years) of persons with laboratory-confirmed Shigella infections reported to CDC 
by species and year, United States, 2000-2010
Species 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010
S. sonnei 8 8 7 7 7 7 7 6 6 6 6
S. flexneri 10 15 21 23 20 20 18 15 17 22 25
S. boydii 25 25 21 17 21 25 10 26 16 17 22
S. dysenteriae 10 28 29 22 9 25 20 8 15 31 28
Unknown 13 23 6 6 7 8 8 9 7 22 8
In 2010, the median age of persons with S. sonnei was 6 years.  The median age has decreased since 2000.  
In contrast, the median age of persons with S. flexneri was 25 years, the highest since 2000.  
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The top panel of this graph shows the incidence rates of infection with Shigella (all species) and Shigella sonnei 
from 1970 to 2010.
 • Since 1970, the incidence rate of infection with Shigella (all species) has been driven by the incidence rate of 
infection with Shigella sonnei.
The bottom panel of this graph shows the incidence rate of infection with all Shigella species other than Shigella 
sonnei and includes infections with an unspecified species.
 • The incidence rate of infection with Shigella flexneri has been decreasing since the 1980s.
 • Since the mid-1980s, the incidence rate of Shigella infection in which the species is not identified has 
fluctuated, likely representing at least to some extent outbreak situations where public health laboratories did 
not characterize all outbreak-associated Shigella isolates to the species level.
 • Shigella boydii and Shigella dysenteriae infections are rare in the United States.
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Figure 2a. Incidence rate of laboratory-confirmed Shigella infection reported to CDC (all species) 
by reporting jurisdiction, United States, 2010
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* Unshaded reporting jurisdictions are those for which the reporting jurisdiction reported no Shigella isolates (i.e., no infections were diagnosed or the 
reporting jurisdiction did not report to CDC). 
Forty-eight reporting jurisdictions reported a total of 8,962 Shigella infections, corresponding to an overall 
incidence rate (cases per 100,000 population) of 2.9.  The reporting jurisdictions with the highest reported 
incidence rates of Shigella infection were Missouri (17.9), New Mexico (9.9), and Texas (8.6). 
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Figure 2b. Incidence rate of laboratory-confirmed human Shigella sonnei infection reported to CDC, 
by reporting jurisdiction, United States, 2010*
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* Unshaded reporting jurisdictions are those for which the reporting jurisdiction reported no Shigella isolates (i.e., no infections were diagnosed or the 
reporting jurisdiction did not report to CDC). 
Forty-six reporting jurisdictions reported a total of 7,122 Shigella sonnei infections, corresponding to an overall 
incidence rate (cases per 100,000 population) of 2.3.  The reporting jurisdictions with the highest reported 
incidence rates of Shigella sonnei infection were Missouri (17.1), New Mexico (8.5), and Texas (7.2). 
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Figure 2c. Incidence rate of laboratory-confirmed Shigella flexneri infection reported to CDC, 
by reporting jurisdiction, United States, 2010* 
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* Unshaded reporting jurisdictions are those for which the reporting jurisdiction reported no Shigella isolates (i.e., no infections were diagnosed or the 
reporting jurisdiction did not report to CDC). 
Forty-seven reporting jurisdictions reported a total of 1,026 Shigella flexneri infections, corresponding to an overall 
incidence rate (cases per 100,000 population) of 0.33.  The reporting jurisdictions with the highest reported 
incidence rates of Shigella flexneri infection were Hawaii (2.9), the District of Columbia (2.3), and Arizona (1.4).
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Figure 3. Incidence rate of laboratory-confirmed Shigella infection reported to CDC, by age group and sex, 
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During 2010, the incidence rate of Shigella infection was highest in children under 5 years old.  From ages 0 to 39, 
females had a higher incidence rate of Shigella infection than males, with an increase in incidence rate of infection 
between ages 20 to 39.  For ages 40 and older, incidence rates of infection were similar among males and females. 
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Figure 4. Number of laboratory-confirmed Shigella isolates reported to CDC by month of specimen collection, 
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Compared to the previous 10 years (2000–2009), fewer Shigella isolates were reported most months in 2010.  
During 2010, reports of Shigella infections did not reflect any distinct seasonality as opposed to reports 
received in the previous ten years, which show a peak in late summer and fall months. 
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Human Surveillance Data: National Notifiable Diseases  
Surveillance System (NNDSS)
The National Notifiable Disease Surveillance System (NNDSS) collects and compiles reports of nationally 
notifiable infectious diseases, including Shigella.  This system includes reports of laboratory-confirmed cases  
and probable cases (clinically compatible cases with an epidemiological link to a confirmed case). 
The 2010 NNDSS report is available at  http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5953a1.htm. 
 • A total of 11,719 confirmed cases of shigellosis were reported to NNDSS during 2010; species information  
was not available in this system for 2010 (2).
Human Antimicrobial Resistance Data: National Antimicrobial Resistance 
Monitoring System (NARMS)
The National Antimicrobial Resistance Monitoring System (NARMS) monitors antimicrobial resistance among 
enteric bacteria (including Shigella) isolated from humans.  The 2010 NARMS report on human isolates is  
available at  http://www.cdc.gov/narms/pdf/2010-annual-report-narms.pdf.
Among the family Enterobacteriaceae, which includes Shigella, resistance to nalidixic acid, an elementary 
quinolone, correlates with decreased susceptibility to ciprofloxacin (MIC ≥0.12 μg/mL) and possible 
fluoroquinolone treatment failure. 
 • 4.4% of Shigella isolates were resistant to nalidixic acid and 1.7% were resistant to ciprofloxacin. 
Multidrug resistance is described in NARMS as resistance to three or more antimicrobial classes, as defined by  
the Clinical and Laboratory Standards Institute (CLSI).
 • 40.0% (163/407) of Shigella isolates were resistant to three or more classes.
Human Outbreak Data: Foodborne Disease Outbreak Surveillance System 
(FDOSS) and Waterborne Disease Outbreak Surveillance System (WBDOSS)
The Foodborne Disease Outbreak Surveillance System (FDOSS) collects reports of foodborne disease outbreaks 
from local, state, and territorial public health agencies.  Reports are available at   
http://www.cdc.gov/outbreaknet/surveillance_data.html.
 • In 2010, 5 confirmed, single-etiology Shigella outbreaks with 385 illnesses were reported; all were  
Shigella sonnei (4).
The Waterborne Disease and Outbreak Surveillance System (WBDOSS) collects reports of waterborne disease 
outbreaks associated with drinking water and recreational water from local, state, tribal, and territorial public 
health agencies.  Reports are available at  http://www.cdc.gov/healthywater/statistics/wbdoss/surveillance.html. 
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